Technical Analysis for TEM - Tempus AI, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 43.51 | -5.84% | -2.70 |
Earnings due: Nov 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Oversold Stochastic | Weakness | 0.00% | |
| Narrow Range Bar | Range Contraction | -5.84% | |
| Gapped Up | Strength | -5.84% | |
| Oversold Stochastic | Weakness | -5.84% | |
| Stochastic Reached Oversold | Weakness | -4.18% | |
| Down 3 Days in a Row | Weakness | -4.18% | |
| Oversold Stochastic | Weakness | -4.18% | |
| Multiple of Ten Bearish | Other | -10.62% | |
| 20 DMA Resistance | Bearish | -11.82% | |
| Shooting Star Candlestick | Bearish | -11.82% |
| Alert | Time |
|---|---|
| Down 5% | 2 days ago |
| Lower Bollinger Band Support | 2 days ago |
| 60 Minute Opening Range Breakdown | 2 days ago |
| Down 3% | 2 days ago |
| Fell Below Previous Day's Low | 2 days ago |
Get a Trading Sidekick!
- Earnings date: 11/07/2024
Tempus AI, Inc. Description
Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a collaboration with united therapeutics to study use of AI to detect patients at risk for pulmonary hypertension. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc in January 2023. Tempus AI, Inc was incorporated in 2015 and is headquartered in Chicago, Illinois.
Classification
Sector: Healthcare
Industry: Health Information Services
Keywords: Biotechnology Pharmaceutical Artificial Intelligence Imaging Healthcare Providers Analytical Services Healthcare Technology Pulmonary Hypertension Genotyping
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 77.0 |
| 52 Week Low | 22.89 |
| Average Volume | 1,082,038 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 52.46 |
| 20-Day Moving Average | 48.93 |
| 10-Day Moving Average | 47.41 |
| Average True Range | 3.57 |
| RSI (14) | 40.83 |
| ADX | 12.96 |
| +DI | 17.70 |
| -DI | 25.55 |
| Chandelier Exit (Long, 3 ATRs) | 46.06 |
| Chandelier Exit (Short, 3 ATRs) | 54.22 |
| Upper Bollinger Bands | 54.84 |
| Lower Bollinger Band | 43.03 |
| Percent B (%b) | 0.04 |
| BandWidth | 24.14 |
| MACD Line | -1.48 |
| MACD Signal Line | -0.99 |
| MACD Histogram | -0.4847 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 47.76 | ||||
| Resistance 3 (R3) | 48.22 | 47.28 | 47.05 | ||
| Resistance 2 (R2) | 47.28 | 46.20 | 47.04 | 46.81 | |
| Resistance 1 (R1) | 45.39 | 45.53 | 44.92 | 44.93 | 46.58 |
| Pivot Point | 44.45 | 44.45 | 44.21 | 44.21 | 44.45 |
| Support 1 (S1) | 42.56 | 43.37 | 42.09 | 42.10 | 40.44 |
| Support 2 (S2) | 41.62 | 42.70 | 41.38 | 40.21 | |
| Support 3 (S3) | 39.73 | 41.62 | 39.97 | ||
| Support 4 (S4) | 39.27 |
